Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Artivion
AORT
Artivion
Global Heart Valve Demand Will Expand Future Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
28 May 25
Updated
24 Jul 25
2
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$32.71
1.7% undervalued
intrinsic discount
24 Jul
US$32.15
Loading
1Y
26.6%
7D
2.1%
Author's Valuation
US$32.7
1.7% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$32.7
1.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-28m
502m
2014
2017
2020
2023
2025
2026
2028
Revenue US$502.3m
Earnings US$31.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
10.56%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.02%
Calculation
US$31.03m
Earnings '28
x
59.37x
PE Ratio '28
=
US$1.84b
Market Cap '28
US$1.84b
Market Cap '28
/
45.23m
No. shares '28
=
US$40.74
Share Price '28
US$40.74
Share Price '28
Discounted to 2025 @ 7.58% p.a.
=
US$32.72
Fair Value '25